Journal ArticleDOI
The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus
Reads0
Chats0
TLDR
Although the inoculum size had no effect on the rate of killing by ciprofloxacin, an increase in turbidity was noted when a high inoculum was tested, which could be misinterpreted as bacterial growth and result in a false report of an elevated MIC.Abstract:
Ciprofloxacin exhibited good in-vitro activity for methicillin-resistant Staphylococcus aureus with a MIC90 of 0.5 mg/l. The postantibiotic effect was 2.16 h. When ciprofloxacin was evaluated in combination studies with an aminoglycoside, none of the strains met the criterion of synergy as defined by FIC or FBC interaction indices of less than or equal to 0.25. However, killing kinetic experiments indicated that the combination of ciprofloxacin was synergistic for two of 12 strains with gentamicin and three of 12 strains with amikacin. Although the inoculum size had no effect on the rate of killing by ciprofloxacin, an increase in turbidity was noted when a high inoculum was tested. This increase in turbidity was due to the swelling of the staphylococci to several times their normal size and the formation of clusters of multicellular, incompletely divided staphylococci. If a high inoculum is used for susceptibility testing, this increase in turbidity could be misinterpreted as bacterial growth and could result in a false report of an elevated MIC.read more
Citations
More filters
Journal ArticleDOI
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Deborah M. Campoli-Richards,Jon P. Monk,Allan H. Price,Paul Benfield,Peter A. Todd,Alan Ward +5 more
TL;DR: As an orally active, broad spectrum and potent antibacterial drug, ciprofloxacin offers a valuable alternative to broad spectrum parenterally administered antibacterial drugs for use in a wide range of clinical infections, including difficult infections due to multiresistant pathogens.
Journal ArticleDOI
Fluoroquinolone antimicrobial agents.
John S. Wolfson,David C. Hooper +1 more
TL;DR: The fluoroquinolones offer an efficacious, well-tolerated, and cost-effective alternative to parenteral therapies of selected infections and show promise for therapy of prostatitis, respiratory tract infections, osteomyelitis, and cutaneous infections.
Journal ArticleDOI
The Medical Complications of Drug Addiction and the Medical Assessment of the Intravenous Drug User: 25 Years Later
TL;DR: This review is intended to provide a historical context to this vast subject and suggest variability in the natural history of intravenous drug use, but as a disease archetype it is a useful pattern for predicting behavior.
Journal ArticleDOI
Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.
TL;DR: Oral and intravenous ciprofloxacin yielded similar clinical and bacteriologic results compared to standard therapy in a wide array of systemic infections, including lower and upper urinary tract infections; gonococcal urethritis; skin, skin structure, and bone infections; and respiratory tract and gastrointestinal tract infections.
Journal ArticleDOI
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
J H Paton,D S Reeves +1 more
TL;DR: The newer fluoroquinolones have an extended antimicrobial spectrum compared to their older congeners, and are highly active against most Gram-negative pathogens including the Enterobacteriaceae and Pseudomonas aeruginosa.
Related Papers (5)
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
John S. Wolfson,David C. Hooper +1 more
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Nai-Xun Chin,H. C. Neu +1 more